Sanofi's chief executive Paul Hudson said he is "excited to partner with Orano in establishing a French pioneer that unites our respective expertise in biopharma and nuclear technology to drive ...

New start-up Uniquity Bio arrived on the scene today with $300 million in funding from Blackstone Life Sciences and a clinical-stage inflammation and immunology drug licensed from MSD. The FDA has ...

Despite these challenges, the company remains cautiously optimistic. George noted, “I am more confident than ever that our team – setting new records with each quarter – has the expertise and drive to ...